TWO SIGMA INVESTMENTS, LP - 4D MOLECULAR THERAPEUTICS IN ownership

4D MOLECULAR THERAPEUTICS IN's ticker is FDMT and the CUSIP is 35104E100. A total of 89 filers reported holding 4D MOLECULAR THERAPEUTICS IN in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of 4D MOLECULAR THERAPEUTICS IN
ValueSharesWeighting
Q3 2023$1,296,716
-61.2%
101,863
-45.0%
0.00%
-62.5%
Q2 2023$3,345,462
-3.1%
185,139
-7.8%
0.01%
-20.0%
Q1 2023$3,453,179
+1.0%
200,883
+30.5%
0.01%
-9.1%
Q4 2022$3,419,763
+2490.7%
153,974
+836.1%
0.01%
Q3 2022$132,000
-58.9%
16,449
-64.2%
0.00%
-100.0%
Q2 2022$321,000
+35.4%
45,995
+193.0%
0.00%0.0%
Q1 2022$237,000
-84.7%
15,700
-77.8%
0.00%
-66.7%
Q4 2021$1,554,00070,8470.00%
Other shareholders
4D MOLECULAR THERAPEUTICS IN shareholders Q3 2022
NameSharesValueWeighting ↓
VR Adviser, LLC 3,000,000$38,190,0004.02%
Casdin Capital, LLC 1,033,811$13,160,4141.46%
BVF INC/IL 4,007,413$51,014,3671.38%
Deep Track Capital, LP 2,778,107$35,365,3021.36%
Opaleye Management Inc. 308,500$3,927,2051.28%
Eagle Health Investments LP 437,911$5,574,6071.23%
Novo Holdings A/S 1,200,000$15,276,0001.13%
RA Capital Management 4,163,211$52,997,6761.04%
VIKING GLOBAL INVESTORS LP 4,787,914$60,950,1450.25%
HighVista Strategies LLC 33,419$425,4240.20%
View complete list of 4D MOLECULAR THERAPEUTICS IN shareholders